A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs

被引:22
作者
Borggren, Marie [1 ]
Nielsen, Jens [1 ]
Karlsson, Ingrid [1 ]
Dalgaard, Tina S. [2 ]
Trebbien, Ramona [3 ]
Williams, James A. [4 ]
Fomsgaard, Anders [1 ,5 ]
机构
[1] Statens Serum Inst, Dept Microbiol Diagnost & Virol, Virus Res & Dev Lab, Artillerivej 5, DK-2300 Copenhagen S, Denmark
[2] Aarhus Univ, Dept Anim Sci, Immunol & Microbiol Lab, Blichers Alle 20, DK-8830 Tjele, Denmark
[3] Statens Serum Inst, Natl Influenza Ctr Denmark, Artillerivej 5, DK-2300 Copenhagen S, Denmark
[4] Nat Technol Corp, 4701 Innovat Dr, Lincoln, NE 68521 USA
[5] Univ Southern Denmark, Inst Clin, Infect Dis Res Unit, Sdr Blvd 29, DK-5000 Odense C, Denmark
关键词
Swine influenza; Polyvalent; DNA; Vaccine; Cross-reactive; Response; SWINE INFLUENZA; A VIRUS; PROTECTIVE IMMUNITY; CLINICAL-TRIALS; PLASMID DNA; T-CELLS; IN-VIVO; INFECTION; CHALLENGE; H1N1;
D O I
10.1016/j.vaccine.2016.05.030
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Pigs are natural hosts for influenza A viruses, and the infection is widely prevalent in swine herds throughout the world. Current commercial influenza vaccines for pigs induce a narrow immune response and are not very effective against antigenically diverse viruses. To control influenza in pigs, the development of more effective swine influenza vaccines inducing broader cross-protective immune responses is needed. Previously, we have shown that a polyvalent influenza DNA vaccine using vectors containing antibiotic resistance genes induced a broadly protective immune response in pigs and ferrets using intradermal injection followed by electroporation. However, this vaccination approach is not practical in large swine herds, and DNA vaccine vectors containing antibiotic resistance genes are undesirable. Objectives: To investigate the immunogenicity of an optimized version of our preceding polyvalent DNA vaccine, characterized by a next-generation expression vector without antibiotic resistance markers and delivered by a convenient needle-free intradermal application approach. Methods: The humoral and cellular immune responses induced by three different doses of the optimized DNA vaccine were evaluated in groups of five to six pigs. The DNA vaccine consisted of six selected influenza genes of pandemic origin, including internally expressed matrix and nucleoprotein and externally expressed hemagglutinin and neuraminidase. Results: Needle-free vaccination of growing pigs with the optimized DNA vaccine resulted in specific, dose-dependent immunity down to the lowest dose (200 pg DNA/vaccination). Both the antibody-mediated and the recall lymphocyte immune responses demonstrated high reactivity against vaccine-specific strains and cross-reactivity to vaccine-heterologous strains. Conclusion: The results suggest that polyvalent DNA influenza vaccination may provide a strong tool for broad protection against swine influenza strains threatening animal as well as public health. In addition, the needle-free administration technique used for this DNA vaccine will provide an easy and practical approach for the large-scale vaccination of swine. (C) 2016 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:3634 / 3640
页数:7
相关论文
共 46 条
  • [21] Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus
    Macklin, MD
    McCabe, D
    McGregor, MW
    Neumann, V
    Meyer, T
    Callan, R
    Hinshaw, VS
    Swain, WF
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (02) : 1491 - 1496
  • [22] Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
    Marcelin, Glendie
    Sandbulte, Matthew R.
    Webby, Richard J.
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2012, 22 (04) : 267 - 279
  • [23] The influence of age and maternal antibodies on the postvaccinal response against swine influenza viruses in pigs
    Markowska-Daniel, Iwona
    Pomorska-Mol, Malgorzata
    Pejsak, Zygmunt
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2011, 142 (1-2) : 81 - 86
  • [24] Emergence and pandemic potential of swine-origin H1N1 influenza virus
    Neumann, Gabriele
    Noda, Takeshi
    Kawaoka, Yoshihiro
    [J]. NATURE, 2009, 459 (7249) : 931 - 939
  • [25] Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene
    Okuda, K
    Ihata, A
    Watabe, S
    Okada, E
    Yamakawa, T
    Hamajima, K
    Yang, J
    Ishii, N
    Nakazawa, M
    Okuda, K
    Ohnari, K
    Nakajima, K
    Xin, KQ
    [J]. VACCINE, 2001, 19 (27) : 3681 - 3691
  • [26] DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza
    Olsen, CW
    [J]. VETERINARY MICROBIOLOGY, 2000, 74 (1-2) : 149 - 164
  • [27] Olsen CW, 2006, DIS SWINE, P469
  • [28] Enhancement of DNA vaccine potency in rhesus macaques by electroporation
    Otten, G
    Schaefer, M
    Doe, B
    Liu, H
    Srivastava, I
    zur Megede, J
    O'Hagan, D
    Donnelly, J
    Widera, G
    Rabussay, D
    Lewis, MG
    Barnett, S
    Ulmer, JB
    [J]. VACCINE, 2004, 22 (19) : 2489 - 2493
  • [29] PROTECTION AGAINST A LETHAL INFLUENZA-VIRUS CHALLENGE BY IMMUNIZATION WITH A HEMAGGLUTININ-EXPRESSING PLASMID DNA
    ROBINSON, HL
    HUNT, LA
    WEBSTER, RG
    [J]. VACCINE, 1993, 11 (09) : 957 - 960
  • [30] Optimal Use of Vaccines for Control of Influenza A Virus in Swine
    Sandbulte, Matthew R.
    Spickler, Anna R.
    Zaabel, Pamela K.
    Roth, James A.
    [J]. VACCINES, 2015, 3 (01): : 22 - 73